OS Therapies, Inc. (OSTX)
1.77
+0.03
(+1.72%)
USD |
NYAM |
Sep 22, 16:00
1.79
+0.02
(+1.13%)
After-Hours: 20:00
OS Therapies Total Assets (Quarterly) : 9.897M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.897M |
| March 31, 2026 | 7.299M |
| December 31, 2025 | 6.840M |
| September 30, 2025 | 8.953M |
| June 30, 2025 | 10.31M |
| March 31, 2025 | 4.250M |
| December 31, 2024 | 5.539M |
| September 30, 2024 | 1.977M |
| June 30, 2024 | 1.342M |
| March 31, 2024 | 1.049M |
| Date | Value |
|---|---|
| December 31, 2023 | 0.7981M |
| September 30, 2023 | 0.6536M |
| June 30, 2023 | |
| March 31, 2023 | 0.9512M |
| December 31, 2022 | 0.5091M |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 324.74M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 20.64M |
| Shareholders Equity (Quarterly) | -10.84M |
| Current Ratio | 0.1764 |